FibroGen, Inc.
CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES
Last updated:
Abstract:
The present invention relates to antibodies that bind to CTGF. The antibodies are particularly directed to regions of CTGF involved in biological activities associated with fibrosis. The invention also relates to methods of using the antibodies to treat disorders associated with CTGF including localized and systemic fibrotic disorders including those of the lung, liver, heart, skin, and kidney.
Status:
Application
Type:
Utility
Filling date:
8 Sep 2020
Issue date:
29 Jul 2021